Show
Sort by
-
Review article: dose optimisation of infliximab for acute severe ulcerative colitis
-
Profile of pediatric Crohn's disease in Belgium
-
A phase II randomized study of combined infusional leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer
-
- Journal Article
- A1
- open access
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis
-
- Conference Paper
- C3
- open access
Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis
-
- Conference Paper
- C3
- open access
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease
-
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn’s disease
-
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
-
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
-
Quality assurance and recommendations for quality assessment of screening colonoscopy in Belgium.
-
Mucosal healing predicts sustained clinical remission in early Crohn's disease
-
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
-
Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study
-
Maintenance therapy for ulcerative colitis has no imact on changes in the extent fo ulcerative colitis. On behalf of the Belgian IBD Research Group
-
A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): Top-down versus step-up strategies
-
A positive response to infliximab in Crohn disease: Association with a higher systemic inflammation before treatment but not with-308 TNF gene polymorphism.
-
The role of aminosalicylates in the treatment of ulcerative colitis.
-
Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up.
-
Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extent and severity of an acute exacerbation of ulcerative colitis.
-
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.